Skip to main content
Log in

Impact of cytochrome P450 genes on suicide attempt and risk

  • Letter to the Editors
  • Published:
European Archives of Psychiatry and Clinical Neuroscience Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Hofer P, Schosser A, Calati R, Serretti A, Massat I, Kocabas NA, Konstantinidis A, Linotte S, Mendlewicz J, Souery D, Zohar J, Juven-Wetzler A, Montgomery S, Kasper S (2013) The impact of Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes on suicide attempt and suicide risk—a European multicentre study on treatment-resistant major depressive disorder. Eur Arch Psychiatry Clin Neurosci. (in press) doi:10.1007/s00406-012-0375-y

  2. Zackrisson AL, Lindblom B, Ahlner J (2010) High frequency of occurrence of CYP2D6 gene duplication/multiduplication indicating ultrarapid metabolism among suicide cases. Clin Pharmacol Ther 88:354–359

    Article  PubMed  CAS  Google Scholar 

  3. Peñas-Lledó EM, Dorado P, Agüera Z, Gratacós M, Estivill X, Llerena A (2011) High risk of lifetime history of suicide attempts among CYP2D6 ultrarapid metabolizers with eating disorders. Mol Psychiatry 16:691–692

    Article  PubMed  Google Scholar 

  4. Peñas-Lledó EM, Blasco-Fontecilla H, Dorado P, Vaquero-Lorenzo C, Baca-García E, Llerena A (2012) CYP2D6 and the severity of suicide attempts. Pharmacogenomics 13:179–184

    Article  PubMed  Google Scholar 

  5. Stingl JC, Viviani R (2011) CYP2D6 in the brain: impact on suicidality. Clin Pharmacol Ther 89:352–353

    Article  PubMed  CAS  Google Scholar 

  6. Peñas-Lledó EM, Trejo HD, Dorado P, Ortega A, Jung H, Alonso E, Naranjo ME, López-López M, Llerena A (2013) CYP2D6 ultrarapid metabolism and early dropout from fluoxetine or amitriptyline monotherapy treatment in major depressive patients. Mol Psychiatry 18:266

    Article  Google Scholar 

  7. Serretti A, Calati R, Massat I, Linotte S, Kasper S, Lecrubier Y, Sens-Espel R, Bollen J, Zohar J, Berlo J, Lienard P, De Ronchi D, Mendlewicz J, Souery D (2009) Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes are not associated with response and remission in a sample of depressive patients. Int Clin Psychopharmacol 24:250–256

    Google Scholar 

  8. Llerena A, Dorado P, Ramírez R, González I, Alvarez M, Peñas-Lledó EM, Pérez B, Calzadilla LR (2012) CYP2D6 genotype and debrisoquine hydroxylation phenotype in Cubans and Nicaraguans. Pharmacogenomics J 12:176–183

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported in part by Union Europea Fondo Social Europeo (FEDER), Instituto de Salud Carlos III-FIS (PI10/02758 to ALL), and Gobierno de Extremadura, Consejería de Empleo Empresa e Innovación, FSE (BS10023 to EMPLL and PD10199 to MEGN).

Conflict of interest

None of the authors has a conflict of interest to declare.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eva M. Peñas-Lledó.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Peñas-Lledó, E.M., Naranjo, M.E.G. & LLerena, A. Impact of cytochrome P450 genes on suicide attempt and risk. Eur Arch Psychiatry Clin Neurosci 263, 703–704 (2013). https://doi.org/10.1007/s00406-013-0402-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00406-013-0402-7

Keywords

Navigation